HR1018LRB099 17084 GRL 41442 r

1
HOUSE RESOLUTION

 
2    WHEREAS, A recent study by the Mayo Clinic found that 7 of
3every 10 Americans currently take at least one prescription
4medication; and
 
5    WHEREAS, The State of Illinois has a population of
6approximately 12.8 million, which equates to nearly 9 million
7Illinois citizens taking prescription drugs; and
 
8    WHEREAS, The number of people who take prescription drugs
9has risen by 5% in recent years; and
 
10    WHEREAS, According to Express Scripts, average prices for
11brand name prescription drugs have risen 128% in recent years;
12and
 
13    WHEREAS, The only 2 countries in the world that allow for
14direct-to-consumer advertising of prescription drugs are the
15United States and New Zealand; and
 
16    WHEREAS, A recent study found that drug makers have spent
17$4.5 billion in the last 2 years on advertising prescription
18drugs, representing a 30% increase in marketing; and
 
19    WHEREAS, There is anecdotal evidence that increased

 

 

HR1018- 2 -LRB099 17084 GRL 41442 r

1marketing of brand name prescription drugs results in patients
2requesting expensive and unnecessary prescriptions, leading to
3increased health-care costs; and
 
4    WHEREAS, At a recent meeting, the American Medical
5Association adopted a policy seeking to ban direct-to-consumer
6advertising of prescription drugs given its concern with
7proliferation of expensive treatments and escalating drug
8prices; therefore, be it
 
9    RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE
10NINETY-NINTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that we
11urge Congress to adopt legislation banning direct-to-consumer
12advertising of prescription drugs; and be it further
 
13    RESOLVED, That we urge the United States Food and Drug
14Administration to adopt appropriate rules and regulations
15banning direct-to-consumer advertising of prescription drugs;
16and be it further
 
17    RESOLVED, That a suitable copy of this resolution be
18presented to the members of the Illinois congressional
19delegation, the United States Food and Drug Administration, and
20the American Medical Association.